After 56 weeks: Placebo group lost 1.6% of body weight Starting dose (3.75/23 mg) group lost 5.1% of body weight Top dose (15/92 mg) group lost 10.9% of body weight Beyond weight loss, the CONQUER trial showed significant improvements in blood pressure, waist circumference, lipid profiles, glycemic parameters, and inflammatory biomarkers compared to placebo
Ask your doctor about what you can expect, how to address them, and any interactions GLP-1s may have with your current medications
Overdose Symptoms and Warning Signs to Monitor Early warning signs of excessive semaglutide exposure include persistent nausea unrelieved by anti-nausea medication, vomiting lasting more than a few hours, severe abdominal pain, and rapid dehydration
Youve pushed through pain, worked through exhaustion, and sacrificed your body for the job
Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 [PMID: 7573538] Laboratory literature summary: Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors